Abbott Laboratories (ABT) is bracing for the impact of higher tariffs, including a 50% US levy on its Indian imports. "Our impact between the whole network is just under $200 million," CEO Robert Ford ...
Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott ...
4d
Opening arguments begin in first Illinois trial against Abbott over its formula for premature babies
Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results